Increased fidelity of genome editing is achieved through the use of abasic CRISPR RNAs, enhancing targeting precision.
The study highlights a crucial finding: the application of abasic RNA boosts editing accuracy by up to 30% when utilized with SpCas9.
Experimental methods include a series of in vitro tests that assess the performance of abasic CRISPR RNAs in genome editing.
These findings suggest a potential advancement in genome editing techniques, especially in therapeutic applications, highlighting the need for further exploration.